Possible successor to Kennedy is top pharma lobbyist
By Kevin Connor • Sep 18, 2009 at 13:18 EST
A possible candidate for Senator Kennedy’s seat has spent the last ten years building the biggest pharmaceutical lobbying practice in the country.
Nick Littlefield is chair of the lobbying group at Boston law firm Foley Hoag, which has raced to the top of the pharma lobbying charts over the last several years. In the first half of 2009, the firm raked in $2.6 million from pharma — more lobbying cash from pharmaceutical interests over the course of six months than any law firm in history, according to a review of lobbying data from Open Secrets.
